Development of a Prognostic Nomogram for Patients with Lung Adenocarcinoma in the Stages I, II, and III Based on Immune Scores

Hui Xie,1,2 Jian-Fang Zhang,3 Qing Li2,4 1Department of Radiation Oncology, Affiliated Hospital (Clinical College) of Xiangnan University, Chenzhou, 423000, Hunan Province, People’s Republic of China; 2Key Laboratory of Medical Imaging and Artificial Intelligence of Hunan Province, Chenzhou, 423000,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Xie H, Zhang JF, Li Q
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/bbd6f49b180e49e5b311b7222e6a8b44
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!